Research Focus
Prostate cancer remains the most commonly diagnosed non-cutaneous cancer in men, with an estimated 1.4 million new diagnoses each year worldwide. The PRE2 CAP laboratory aims to discover environmental risk factors for prostate cancer, and address barriers to appropriate prostate cancer screening and treatment through application of geospatial analytic methods.
Please visit our laboratory webpage to learn more about our work.
Projects
Multilevel Tumor Registry for Oncology (METRO)
Dr. Iyer co-leads the Multilevel Tumor Registry for Oncology (METRO) registry cohort of men with prostate cancer. Through this work, we hope to improve understanding of specific geographic access barriers that may prevent all men from receiving appropriate prostate cancer screening and treatment.
Research on the Epidemiology of Prostate Cancer and Environmental Levels (REPEL)
Dr. Iyer also co-leads the Research on the Epidemiology of Prostate Cancer and Environmental Levels (REPEL) study of environmental risk factors for prostate cancer progression. We hope to improve our understanding of how environmental contaminants, including forever chemicals, may influence quality of life and survival in men with prostate cancer.
Publications
Dr. Iyer has co-authored over 100 peer-reviewed publications across multiple fields of public health, including cancer epidemiology, environmental health, and global health. View Dr. Iyer's publications on MyNCBI.
Current Research Funding
NIEHS K01ES035734PI: Iyer
NCI R01CA315618PI: Zeinomar
NCI R01CA312608MPI: Ergas, Khosrow-Khavar
NCI P30CA072720 New Investigator Pilot Award
VHA I01 RD001892PI: Pyarajan
VHA I01 RD001166MPI: Garraway, Vassy
American Cancer Society RSG-23-1143513-01-CTPSPI: Qin
Prostate Cancer Research Program Health Disparity Research Award PC220551PI: Trinh
Previous Research Funding
Prostate Cancer Research, UKMPI: Iyer, Rebbeck
Rutgers Cancer Institute Cancer Prevention and Control Stimulus Award
Rutgers Global Health Institute Pilot
NIEHS P30ES005022 Pilot Award